Representative matters that are public include representation of GlaxoSmithKline in corporate integrity agreement negotiation; representation of Genentech Inc in connection with a lengthy criminal and civil investigation regarding Rituxan; favourably resolving a case brought against client Novo Nordisk regarding allegations of illegal promotional activity; representation of GE Healthcare in connection with an investigation of the company's pricing and promotion of a radiopharmaceutical product; and defending Eli Lilly and Company in two investigations by federal and state prosecutors.
Paul is an author, along with Robert Fabrikant, Mark Hopson and Pamela Bucy, of Health Care Fraud: Enforcement and Compliance and has written numerous articles in legal, medical, and industry publications.
Paul is a graduate of Yale Law School, where he was an editor of the Yale Law Journal. Prior to attending law school, he received his MD degree, magna cum laude, from the Boston University School of Medicine and completed his residency in internal medicine at the New York Hospital-Cornell Medical Center.
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Shop.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.